MBOT vs OKTA · rev $346.0K vs P/E 84, rev $1.57B
Microbot Medical Inc (MBOT) versus Okta Inc (OKTA) — a side-by-side from cached financials, not a winner call.
Microbot Medical Inc (MBOT) is a medical instruments & supplies company listed on NASDAQ.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Latest reported MBOT revenue for 2026-06-30 was $346.0K. Net income was -$9.3M. MBOT currently screens at market cap $123.9M.
Latest reported OKTA revenue for 2026-07-31 was $1.57B. Net income was $190.0M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
MBOT currently screens at market cap $123.9M. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
Not investment advice. Open the MBOT and OKTA stock pages for the full models.
Not investment advice.